P-9 A randomized study of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 as first-line treatment for unresectable metastatic colorectal cancer
Belhadef, S., Arab, A., Belmadi, M., Beninal, M., Bacha, N., Abdallah, R., Mechta, K., Dahmane, A., Mahfouf, H., Oukkal, M., Bouzid, K., Faraqun, S., Bentabak, K., Younes, S. Ait
Published in Annals of oncology (01.07.2020)
Published in Annals of oncology (01.07.2020)
Get full text
Journal Article